Cost-effectiveness of treatments for high-risk myelodysplastic syndromes after failure of first-line hypomethylating agent therapy.
about
Cost-effectiveness of treatments for high-risk myelodysplastic syndromes after failure of first-line hypomethylating agent therapy.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Cost-effectiveness of treatmen ...... hypomethylating agent therapy.
@en
Cost-effectiveness of treatmen ...... hypomethylating agent therapy.
@nl
type
label
Cost-effectiveness of treatmen ...... hypomethylating agent therapy.
@en
Cost-effectiveness of treatmen ...... hypomethylating agent therapy.
@nl
prefLabel
Cost-effectiveness of treatmen ...... hypomethylating agent therapy.
@en
Cost-effectiveness of treatmen ...... hypomethylating agent therapy.
@nl
P2093
P2860
P1476
Cost-effectiveness of treatmen ...... hypomethylating agent therapy.
@en
P2093
Ayanna M Anene
Christopher R Cogle
Jesse D Ortendahl
Michael E Petrone
Scott Megaffin
Sudipto Mukherjee
Tanya Gk Bentley
Thomas J McKearn
P2860
P304
P356
10.1586/14737167.2016.1096200
P577
2015-11-20T00:00:00Z